Investigation Overview
Jan. 29, 2013 (Shareholders Foundation) -- An investigation on behalf of current long term investors in shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) was announced concerning whether certain officers and directors of Raptor Pharmaceutical Corp. breached their fiduciary duties by paying certain top officials at Raptor Pharmaceutical excessive compensation. The investigation by a...
You must register (for free) or login to view the entire investigation.